Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06349837
Status:
RECRUITING
Last Update Posted:
2024-04-05
First Post:
2024-03-31
Brief Title:
Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
Sponsor:
Organization:
Sichuan University